Fundraising Fox
/Companies
Sign in

Delphinus Medical Technologies

Novi, US · Founded 2010 · Delaware corporation · 6 known investors

Find your way into Delphinus Medical Technologies

Sign up to see every warm intro you have to Delphinus Medical Technologies

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Delphinus Medical Technologies team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in
Biotech

Founders & leadership

Delphinus Medical Technologies was founded in 2010 by Neb Duric, Ph.D..

ND
Neb Duric, Ph.D.Founder
SWScott White
Scott WhiteExecutive
EBElise Berman
Elise BermanExecutive
CS
Chris SandersExecutive
HR
Heather RoneExecutive
DS
Debra SaundersExecutive
SO
Shawn O'BrienExecutive

Board

HB
Hugo BraunBoard director
JN
John NeisBoard director
MF
Michael FultonBoard director
RH
Ronald HoBoard director
MGMichael Gross
Michael GrossBoard directorManaging Partner at Beringea

Investors · 6

BeringeareportedLondon · $3M – $10M

How we know: a partner's Signal profile · funding news · delphinusmt.com · Not right? Tell us

Clarevia VenturesreportedMadison · $250K – $2.5M

How we know: funding news · delphinusmt.com · Not right? Tell us

Also in the syndicate · 3

Hopen Life Science VenturesNorth Coast Technology InvestorsWaycross Ventures

Reported raises · per SEC filings

Form D private placements

$110.8M disclosed across 5 rounds · 2015–2024

▶$27.6MraisedApr 2025 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Hugo BraunDirector
  • John NeisDirector
  • Michael FultonDirector
  • Ronald HoDirector
  • Rachel BremDirector
  • Scott WhiteExecutive Officer, Director
  • Mark ForchetteDirector
  • Elise BermanExecutive Officer
  • Michael GrossDirector
Offering amount
$27.6M
Amount sold
$27.6M
First sale
Mar 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedJun 2023 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael FultonDirector
  • Mark ForchetteExecutive Officer, Director
  • Michael GrossDirector
  • Shawn O'BrienExecutive Officer
  • Paul McCreadieDirector
  • Heather RoneExecutive Officer
  • Rachel BremDirector
  • Ronald HoDirector
  • Neb DuricExecutive Officer
  • John NeisDirector
  • Hugo BraunDirector
  • Olivier RoyExecutive Officer
Offering amount
$8M
Amount sold
$5M
First sale
Jun 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$30.4MraisedSep 2022 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Neb DuricExecutive Officer
  • Shawn O'BrienExecutive Officer
  • Rachel BremDirector
  • Hugo BraunDirector
  • Heather RoneExecutive Officer
  • Olivier RoyExecutive Officer
  • Michael GrossDirector
  • Paul McCreadieDirector
  • Ronald HoDirector
  • Michael FultonDirector
  • Mark ForchetteExecutive Officer, Director
  • John NeisDirector
Offering amount
$30.4M
Amount sold
$30.4M
First sale
Aug 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$8.2MraisedApr 2017 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • John NeisDirector
  • Heather RoneExecutive Officer
  • Paul McCreadieDirector
  • Debra SaundersExecutive Officer
  • Michael FultonDirector
  • Michael GrossDirector
  • Neb DuricExecutive Officer
  • Ronald HoDirector
  • Mark ForchetteExecutive Officer, Director
  • Francis DobschaExecutive Officer
  • Shawn O'BrienExecutive Officer
  • Hugo BraunDirector
Offering amount
$25M
Amount sold
$8.2M
First sale
Apr 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$39.5MraisedSep 2015 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael GrossDirector
  • Hugo BraunDirector
  • Paul McCreadieDirector
  • Chris SandersExecutive Officer
  • John NeisDirector
  • Heather RoneExecutive Officer
  • Ronald HoDirector
  • Michael FultonDirector
  • Neb Duric, Ph.D.Executive Officer
  • Debra SaundersExecutive Officer
  • Mark J. ForchetteExecutive Officer, Director
  • Shawn O'BrienExecutive Officer
Offering amount
$45M
Amount sold
$39.5M
First sale
Aug 2015
Incorporated
Corporation, Delaware, 2010
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who founded Delphinus Medical Technologies?
Delphinus Medical Technologies was founded by Neb Duric, Ph.D. in 2010.
Who are Delphinus Medical Technologies's investors?
Delphinus Medical Technologies's investors include Arboretum Ventures, Beringea, Clarevia Ventures.
How much funding has Delphinus Medical Technologies raised?
Delphinus Medical Technologies has disclosed $110.8M raised across 5 rounds.
Where is Delphinus Medical Technologies headquartered?
Delphinus Medical Technologies is headquartered in Novi, US.